β-methyl-p-(123I)-iodophenyl pentadecanoic acid single-photon emission computed tomography in cardiomyopathy

International Journal of Cardiac Imaging

Volumn 15, Issue 1, 1999, Pages 41-48

  Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

123I BMIPP; CD36 deficiency; Dilated cardiomyopathy; Hypertrophic cardiomyopathy

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; CD36 ANTIGEN; FLUORODEOXYGLUCOSE F 18; THALLIUM 201; UBIDECARENONE;

CARDIOMYOPATHY; DIAGNOSTIC ERROR; DISEASE COURSE; DISEASE SEVERITY; DRUG RETENTION; DRUG UPTAKE; HEART DILATATION; HEART FUNCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ANTIGENS, CD36; ANTIOXIDANTS; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; FATTY ACIDS; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; UBIQUINONE;

EID: 0032802224     PISSN: 01679899     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006188301035     Document Type: Review

References (30)

1. Knapp FF, Kropp J. Iodine-123-labelled fatty acids for myocardial single photon emission tomography: Current status and future prospective. Eur J Nucl Med 1995; 22: 361-381
2. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of Iodine-123-BMIPP in perfused rat heart. J Nucl Med 1995; 36: 1043-1050
3. Morishita S, Kusuoka H, Yamamichi Y, et al. Kinetics of radioiodinated species in subcellular fraction from rat hearts following administration of Iodine-123-labelled 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid. Eur J Nucl Med 1996; 23: 383-389
4. 123I)-iodophenyl petadecanoic acid single photon emission computed tomography in cardiac disease. J Nucl Cardiol 1994;1: S65-71
5. 201TI SPECT imaging. Eur J Nucl Med 1996; 23: 917-923
6. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994; 35: 1758-1765
7. Maron BJ and Epstein SE. Hypertrophic cardiomyopathy: Recent observations regarding the specificity of three handmarks of the disease: asymmetric hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral anterior leaflet. Am J Cardiol 1980; 45: 141-154
8. Maron BJ, Bonow RO III, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987; 316-780-789, 844-852
9. Uehara T, Ishida Y, Hayashida K, et al. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study. Ann Nucl Med 1998; 12: 95-103
10. Henry WL, Clark CE, Epstein SE. Asymmetric septal hypertrophy: echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 1973; 47: 225-233
11. Shimonagata T, Nishimura T, Uehara T, et al. Discrepancies between myocardial perfusion and free fatty acid metabolism in patients with hypertrophic cardiomyopathy. Nucl Med Comm 1993; 14: 1005-1013
12. Kurata C, Tawarahara K, Taguchi T, Aoshima S, Kobayashi A, Yamazaki N. Myocardial emission computed tomography with iodine-123-labeled beta-methyl-branched fatty acid in patients with hypertrophic cardiomyopathy. J Nucl Med 1992; 33: 6-13
13. Nishimura T. Approaches for identity and characterize hypertrophic myocardium. J Nucl Med 1993; 34: 1013-1019
14. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intermural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8: 545-557
15. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979; 43: 1086-1102
16. 123I-BMIPP myocardial single photon emission computed tomography. Ann Nucl Med 1996; 7: 71-78
17. Report of the WHO ISFC task force in the definition and classification of cardiomyopathes. Circulation 1996; 93: 841-842
18. Johnson RA, Palacious I. Dilated cardiomyopathy of the adult. N Engl J Med 1982; 307: 1051-1058
19. Dunn RF, Uren RP, Sadik N, et al, Comparison of thallium-201 scanning in idiopathic dilated cardiomyopathy and severe coronary artery disease. Circulation 1982; 66: 804-810
20. 123I-BMIPP scanning for distinction of ischemic from non ischemic dilated cardiomyopathy. Jpn J Nucl Med 1995; 33: 19-25
21. Hatefi Y, Haavik AG, Griffiths DE. Reconstitution of the electron transport. Biochem Biophys Res Commu 1961; 4: 447-453
22. Folkers K, Littarru GP, Runge TM, Havanonda S, Colley D. Evidence for a deficiency of co-enzyme Q10 in human heart disease. Int J vitam Nutr Res 1977; 40: 380-390
23. Langsjoen P, Vadhanavikit S, Folkers K. Response of patients in classes II and IV of cardiomyopathy to therapy in a blind and crossovers trial with co-enzyme Q10. Proc Natl Acad Sci USA 1985; 82: 4240-4244
24. 123T-BMIPP myocardial single-photon emission tomography. Eur J Nucl Med 1997; 24: 629-634
25. Kudoh T, Tamaki N, Magata Y, et al. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP. J Nucl Med 1997; 38: 548-553
26. a, on platelet membrane glycoprotein IV. Blood 1990; 75: 684-687
27. Greenwalt DE, Lipsky, RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992; 80: 1105-1115
28. Abumrad NA, el-Maghrabi MM, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 1993; 268: 17665-17668
29. Fukuchi K, Nozaki S, Yoshizumi T, et al. Enhanced myocardial glucose uptake in individuals with a deficiency in long-chain fatty acid transport (CD36 deficiency). J Nucl Med 1998; 39 (in press)
30. Tanaka T, Sohmiya K, Kuwamura K. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 1997; 29: 121-127